As CEO of Ambu, Juan Jose Gonzalez has looked forward to announcements of tenders for single-use endoscopes in the US. However, competitors are homing in on Ambu's key business area.
The CEO expects duodendoscopes to be the biggest market within single-use endoscopes in 2024-2025, so although the company only recently launched its current product in the US, Gonzalez is already throwing his weight behind the development and launch of the next generation, while competitors circle ahead.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.